Ameritas Investment Partners’s CorMedix CRMD Stock Holding History

Ameritas Investment Partners’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$44.6K	Hold	6,562	–	–	﹤0.01%	2151
2025 Q4	$76.3K	Hold	6,562	–	–	﹤0.01%	1856
2025 Q3	$76.3K	Hold	6,562	–	–	﹤0.01%	1853
2025 Q2	$80.8K	Buy	6,562 +998	+18%	+$11K	﹤0.01%	1897
2025 Q1	$34.3K	Hold	5,564	–	–	﹤0.01%	2312
2024 Q4	$45.1K	Hold	5,564	–	–	﹤0.01%	2249
2024 Q3	$45K	Buy	5,564 +1,879	+51%	+$10.2K	﹤0.01%	2259
2024 Q2	$16K	Hold	3,685	–	–	﹤0.01%	2714
2024 Q1	$15.6K	Hold	3,685	–	–	﹤0.01%	2667
2023 Q4	$13.9K	Hold	3,685	–	–	﹤0.01%	2735
2023 Q3	$13.6K	Hold	3,685	–	–	﹤0.01%	2702
2023 Q2	$14.6K	Buy	+3,685	New	+$18.2K	﹤0.01%	2722
2022 Q2	–	Sell	-2,679	Closed	-$15K	–	3099
2022 Q1	$15K	Hold	2,679	–	–	﹤0.01%	2662
2021 Q4	$12K	Hold	2,679	–	–	﹤0.01%	2837
2021 Q3	$12K	Hold	2,679	–	–	﹤0.01%	2886
2021 Q2	$18K	Hold	2,679	–	–	﹤0.01%	2782
2021 Q1	$27K	Buy	2,679 +600	+29%	+$6.32K	﹤0.01%	2420
2020 Q4	$15K	Hold	2,079	–	–	﹤0.01%	2607
2020 Q3	$13K	Hold	2,079	–	–	﹤0.01%	2586
2020 Q2	$13K	Hold	2,079	–	–	﹤0.01%	2567
2020 Q1	$7K	Hold	2,079	–	–	﹤0.01%	2675
2019 Q4	$15K	Hold	2,079	–	–	﹤0.01%	2547
2019 Q3	$13K	Hold	2,079	–	–	﹤0.01%	2606
2019 Q2	$19K	Buy	+2,079	New	+$16.3K	﹤0.01%	2462

Other funds holding CRMD

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Ameritas Investment Partners's CRMD Position: Q1 2026 in Review

Ameritas Investment Partners held its CorMedix (CRMD) position steady in Q1 2026 at 6,562 shares worth $44.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2151.

Ameritas Investment Partners first reported a position in CRMD in Q2 2019 and has held it in 24 quarters since. The position peaked at $80.8K in Q2 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

Ameritas Investment Partners held 6,562 shares of CorMedix worth $44.6K as of Q1 2026.
Ameritas Investment Partners left its CorMedix share count unchanged in Q1 2026.
CorMedix made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2151 holding.
Ameritas Investment Partners first reported a position in CorMedix in Q2 2019 and has held it in 24 quarters since.
Ameritas Investment Partners's CorMedix position peaked at $80.8K in Q2 2025.
187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.